Literature Study: Acute Myeloid Leukimia (AML)
DOI:
10.29303/jbt.v25i4.10082Published:
2025-10-01Downloads
Abstract
Leukemia is a cancer that originates from cells that initially develop into blood cells. Leukemia can be classified as acute or chronic, depending on how quickly the disease appears and how it progresses in the body. This literature review aims to determine the treatment for patients with AML depending on the subtype. This literature review used journal review methods and data searches through various sources. The results of the literature study found that Acute Myeloid Leukemia (AML) is divided into six subtypes. AML is caused by clonal transformation of hematopoietic cells through chromosomal abnormalities and gene mutations, with risk factors including exposure to radiation, benzene, smoking, chemotherapy therapy, the development of chronic myeloid neoplasms, aging, and predisposing diseases. Diagnosis of AML involves peripheral blood and bone marrow analysis, immunophenotyping, cytogenetics, molecular cytogenetics, and imaging to detect the presence and characteristics of leukemic cells. Treatment of AML includes induction therapy, consolidation therapy, and response monitoring, with special considerations for the selection of chemotherapy regimens, stem cell transplantation, and transfusion support to manage associated complications. In conclusion, Acute Myeloid Leukemia (AML) is a condition in which myeloblasts undergo excessive proliferation and fail to differentiate into granulocytes. This condition causes the bone marrow to fill with myeloblasts.
Keywords:
Acute Myeloid Leukemia (AML) Hematopoiesis LeukemiaReferences
Agusti, M. P., & Rizona, F. (2021). Penatalaksanaan Terapi Dan Efektivitas Pengobatan Pada Pasien Anak Dengan Acute Myeloid Leukemia. In Proceeding Seminar Nasional Keperawatan (Vol. 7, No. 1, pp. 110-115). https://conference.unsri.ac.id/index.php/SNK/article/view/2383
Akmaljon o‘g, A. M. M., Abdullajon o‘g‘li, M. S., & Alimardonovich, M. H. (2024). LEUKEMIA–TYPES, CLINICAL APPEARANCES, DIAGNOSIS AND TREATMENT. Web of Medicine: Journal of Medicine, Practice and Nursing, 2(4), 10-17. https://webofjournals.com/index.php/5/article/view/1080
American Cancer Society, Acute Myeloid Leukaemia (2023). Cancer Statistics Facts: Leukemia – Acute Myeloid Leukemia (AML)
Humphry, E., & Armstrong, C. E. (2022). Physiology of red and white blood cells. Anaesthesia & Intensive Care Medicine, 23(2), 118-122. https://doi.org/10.1016/j.mpaic.2021.10.019
Hwang S. M. (2020). Classification of acute myeloid leukemia. Blood research, 55(S1), S1–S4. https://doi.org/10.5045/br.2020.S001
Jagannathan-Bogdan, M., & Zon, L. I. (2013). Hematopoiesis. Development (Cambridge, England), 140(12), 2463–2467. https://doi.org/10.1242/dev.083147
Kaushansky, K., Lichtman, M. A., Prchal, J. T., Levi, M. M., Press, O. W., Burns, L. J., & Caligiuri, M. A. Kaushansky, K. (2016). Williams hematology. McGraw-Hill Education.
Lagunas-Rangel, F. A., Chávez-Valencia, V., Gómez-Guijosa, M. Á., & Cortes-Penagos, C. (2017). Acute myeloid leukemia—genetic alterations and their clinical prognosis. International journal of hematology-oncology and stem cell research, 11(4), 328. https://pubmed.ncbi.nlm.nih.gov/29340131/
Libourel, E. J., Klerk, C. P., van Norden, Y., de Maat, M. P., Kruip, M. J., Sonneveld, P., ... & Leebeek, F. W. (2016). Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia. Blood, The Journal of the American Society of Hematology, 128(14), 1854-1861. 10.1182/blood-2016-02-701094
Martínez-Cuadrón, D., Serrano, J., Gil, C., Tormo, M., Martínez-Sánchez, P., Pérez-Simón, J. A., ... & Montesinos, P. (2021). Evolving treatment patterns and outcomes in older patients (≥ 60 years) with AML: changing everything to change nothing?. Leukemia, 35(6), 1571-1585. 10.1038/s41375-020-01058-4
Mulanovich, V., & Kontoyiannis, D. P. (2018). Acute myeloid leukemia and the infectious diseases consultant. Leukemia & Lymphoma, 59(6), 1284–1291. https://doi.org/10.1080/10428194.2017.1365861
Nugraha, I. B. A., & Adnyana, W. L. (2017). Seorang Penderita Acute Myeloid Leukemia (AML) M4 yang Mengalami Tumor Lysis Syndrome. Jurnal Penyakit Dalam Udayana, 1(1), 8-16. https://doi.org/10.36216/jpd.v1i1.8
Ok, C. Y., & Hasserjian, R. P. (2017). Leukocytosis: neutrophilia, basophilia, and blasts. In Diagnosis of Blood and Bone Marrow Disorders (pp. 135-170). Cham: Springer International Publishing. 10.1007/978-3-319-20279-2_5
Rahmawati, F. (2022). Aspek Laboratorium Acute Promyelocytic Leukemia (APL) AML-M3. Jurnal Ilmiah Kedokteran Wijaya Kusuma, 2(1), 34-47. http://dx.doi.org/10.30742/jikw.v2i1.35
Robier, C. (2020). Platelet morphology. Journal of Laboratory Medicine, 44(5), 231-239. 10.1109/ACCESS.2021.3114059
Rose, G., Reinhard, H., & Kahwash, S. B. (2020). Is this a blast? An illustrated practical review on peripheral blood smear examination in the paediatric patient. The Malaysian Journal of Pathology, 42(1), 37-49. https://pubmed.ncbi.nlm.nih.gov/32342929/
Sativa, S. O. (2020). Pengaruh Genetik, Gaya Hidup Dan Lingkungan Pada Kejadian Leukemia Mieloblastik Akut. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 8(1), 83-88. https://doi.org/10.53366/jimki.v8i1.42
Sepiwiryanti, W., & Sari, S. D. (2024). Transplantasi Stem Cell Sebagai Pengobatan Kelainan Darah. Stetoskop: The Journal Of Health Science, 1(1), 26-33.
Shah, A., Naqvi, S. S., Naveed, K., Salem, N., Khan, M. A., & Alimgeer, K. S. (2021). Automated diagnosis of leukemia: a comprehensive review. IEEE Access, 9, 132097-132124. 10.1109/ACCESS.2021.3114059
Soares, S. C., Roux, L. J., Castro, A. R., Silva, C. C., Rodrigues, R., Macho, V. M., ... & Costa, C. (2023). Oral manifestations: A warning-sign in children with hematological disease acute lymphocytic leukemia. Hematology reports, 15(3), 491-502. 10.3390/hematolrep15030051
Strickland SA, Vey N. Diagnosis and treatment of therapy-related acute myeloid leukemia. Crit Rev Oncol Hematol. 2022 Mar;171:103607. doi: 10.1016/j.critrevonc.2022.103607
Vakiti A, Reynolds SB, Mewawalla P. Acute Myeloid Leukemia. [Updated 2024 Apr 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507875/
Vinholt, P. J., Højrup Knudsen, G., Sperling, S., Frederiksen, H., & Nielsen, C. (2019). Platelet function tests predict bleeding in patients with acute myeloid leukemia and thrombocytopenia. American journal of hematology, 94(8), 891-901. 10.1002/ajh.25512
Wachter, F., & Pikman, Y. (2024). Pathophysiology of Acute Myeloid Leukemia. Acta Haematologica, 147(2), 232–249. https://doi.org/10.1159/000536152
Weiskopf, K., Schnorr, P. J., Pang, W. W., Chao, M. P., Chhabra, A., Seita, J., ... & Weissman, I. L. (2017). Myeloid cell origins, differentiation, and clinical implications. Myeloid Cells in Health and Disease: A Synthesis, 857-875.
Wierzbowska, A., & Czemerska, M. (2021). Clinical Manifestation and Diagnostic Workup. In Acute Myeloid Leukemia (pp. 119-126). 10.1007/978-3-030-72676-8_6
Yang, F., Lai, J., Deng, J., Du, J., Du, X., Zhang, X., ... & Wu, J. (2023). The application of ethnomedicine in modulating megakaryocyte differentiation and platelet counts. International Journal of Molecular Sciences, 24(4), 3168. 10.3390/ijms24043168
Yuliana, Y.(2017). Perkembangan Terapi Leukemia Mieloid Akut. Cermin Dunia Kedokteran, 44(3), 397578. 10.55175/cdk.v44i3.835
License
Copyright (c) 2025 Evane Dyahayu Pramesti, Ni Made Saithanya Gitanjali Dhevi, Syalsa Hudhori, Ericha Zabrina Salsabila, Isna Asriantin, Joko Anggoro
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
